345 related articles for article (PubMed ID: 11733063)
1. A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth.
Trusolino L; Bertotti A; Comoglio PM
Cell; 2001 Nov; 107(5):643-54. PubMed ID: 11733063
[TBL] [Abstract][Full Text] [Related]
2. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation.
Mainiero F; Murgia C; Wary KK; Curatola AM; Pepe A; Blumemberg M; Westwick JK; Der CJ; Giancotti FG
EMBO J; 1997 May; 16(9):2365-75. PubMed ID: 9171350
[TBL] [Abstract][Full Text] [Related]
3. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
Day RM; Soon L; Breckenridge D; Bridges B; Patel BK; Wang LM; Corey SJ; Bottaro DP
Oncogene; 2002 Mar; 21(14):2201-11. PubMed ID: 11948403
[TBL] [Abstract][Full Text] [Related]
4. The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.
Fan S; Ma YX; Gao M; Yuan RQ; Meng Q; Goldberg ID; Rosen EM
Mol Cell Biol; 2001 Aug; 21(15):4968-84. PubMed ID: 11438654
[TBL] [Abstract][Full Text] [Related]
5. The intracellular functions of alpha6beta4 integrin are regulated by EGF.
Mainiero F; Pepe A; Yeon M; Ren Y; Giancotti FG
J Cell Biol; 1996 Jul; 134(1):241-53. PubMed ID: 8698818
[TBL] [Abstract][Full Text] [Related]
6. Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion.
Shaw LM
Mol Cell Biol; 2001 Aug; 21(15):5082-93. PubMed ID: 11438664
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
Gu J; Tamura M; Yamada KM
J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
[TBL] [Abstract][Full Text] [Related]
8. EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion.
Mariotti A; Kedeshian PA; Dans M; Curatola AM; Gagnoux-Palacios L; Giancotti FG
J Cell Biol; 2001 Oct; 155(3):447-58. PubMed ID: 11684709
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling.
Mood K; Saucier C; Ishimura A; Bong YS; Lee HS; Park M; Daar IO
J Cell Physiol; 2006 Apr; 207(1):271-85. PubMed ID: 16331688
[TBL] [Abstract][Full Text] [Related]
10. Retooling of the beta 4 integrin in tumor cells--ligands lost and kinase gained.
Hemler ME
Dev Cell; 2001 Dec; 1(6):728-30. PubMed ID: 11740933
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M
Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219
[TBL] [Abstract][Full Text] [Related]
12. Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).
Carpenter BL; Chen M; Knifley T; Davis KA; Harrison SMW; Stewart RL; O'Connor KL
J Biol Chem; 2015 Nov; 290(45):27228-27238. PubMed ID: 26381405
[TBL] [Abstract][Full Text] [Related]
13. Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.
Salvatore D; Melillo RM; Monaco C; Visconti R; Fenzi G; Vecchio G; Fusco A; Santoro M
Cancer Res; 2001 Feb; 61(4):1426-31. PubMed ID: 11245446
[TBL] [Abstract][Full Text] [Related]
14. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor.
Hayashi H; Ichihara M; Iwashita T; Murakami H; Shimono Y; Kawai K; Kurokawa K; Murakumo Y; Imai T; Funahashi H; Nakao A; Takahashi M
Oncogene; 2000 Sep; 19(39):4469-75. PubMed ID: 11002419
[TBL] [Abstract][Full Text] [Related]
15. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
Qiao H; Saulnier R; Patryzkat A; Rahimi N; Raptis L; Rossiter J; Tremblay E; Elliott B
Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768
[TBL] [Abstract][Full Text] [Related]
16. The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering.
Tulasne D; Paumelle R; Weidner KM; Vandenbunder B; Fafeur V
Mol Biol Cell; 1999 Mar; 10(3):551-65. PubMed ID: 10069803
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.
Sakata H; Takayama H; Sharp R; Rubin JS; Merlino G; LaRochelle WJ
Cell Growth Differ; 1996 Nov; 7(11):1513-23. PubMed ID: 8930401
[TBL] [Abstract][Full Text] [Related]
18. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
19. Growth defects induced by perturbation of beta1-integrin function in the mammary gland epithelium result from a lack of MAPK activation via the Shc and Akt pathways.
Faraldo MM; Deugnier MA; Thiery JP; Glukhova MA
EMBO Rep; 2001 May; 2(5):431-7. PubMed ID: 11375936
[TBL] [Abstract][Full Text] [Related]
20. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
